Cyrus Biotechnology, Inc.
Cyrus Biotechnology, Inc., commonly referred to as Cyrus Bio, is a pioneering company headquartered in the United States, with significant operations across various regions. Founded in 2014, Cyrus Bio operates at the intersection of biotechnology and computational science, specialising in protein design and engineering. The company is renowned for its innovative software solutions, particularly the Cyrus Bench platform, which streamlines the process of protein design, making it accessible and efficient for researchers and biopharmaceutical companies. With a strong focus on enhancing drug development and therapeutic applications, Cyrus Bio has established itself as a leader in the biotech industry, recognised for its unique approach to computational protein design. Through its commitment to advancing biotechnological research, Cyrus Bio continues to achieve notable milestones, solidifying its position as a key player in the evolving landscape of biotechnology.
DitchCarbon Score
How does Cyrus Biotechnology, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Computer Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Cyrus Biotechnology, Inc.'s score of 14 is lower than 91% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Cyrus Biotechnology, Inc.'s reported carbon emissions
In 2023, Cyrus Biotechnology, Inc. reported no specific carbon emissions data, indicating a total of 0 kg CO2e across all scopes. The company has not disclosed any emissions under Scope 1, Scope 2, or Scope 3, nor has it set any reduction targets or initiatives related to carbon emissions. Cyrus Biotechnology's commitment to climate action appears to be minimal, as there are no significant reduction targets or climate pledges documented. The absence of emissions data suggests that the company may be in the early stages of developing a comprehensive climate strategy or may not have substantial emissions to report. As of now, there are no cascaded emissions data from a parent or related organization, indicating that the company operates independently in this regard. Overall, Cyrus Biotechnology, Inc. has yet to establish a clear framework for addressing carbon emissions and climate commitments.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Cyrus Biotechnology, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
